SOSV

BioLumen is a nutritional technology company that develops a patented dietary fiber technology platform that reduces the negative effect of a diet heavy in processed foods. BioLumen's technology is composed of insoluble dietary fiber matrix covered with a blend of food ingredients created from the latest drug delivery system research. The company's product, a nutraceutical, focuses on high risk individuals with prediabetes to help manage blood sugar levels, protect their liver from excess sugar and feed their gut microbiome, delivering health benefits. BioLumen was founded on 2018 and is headquartered in San Francisco, California.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

PluriCell wants to positively impact the lives of millions of patients suffering from chronic heart failure condition by injecting healthy bona fide lab-made human heart cells in their failing heart, improve its function and, ultimately, the clinical outcome of the patients. Our tech enables us not only tackle heart diseases, but potentially, many chronic disorders currenly untractable.

Sóliome is a biotechnology company founded in 2021 and based in San Francisco, California. The company specializes in developing protein-based sunscreens designed to be safe for both the skin and the environment. These innovative products aim to reduce inflammation and skin damage caused by traditional sunscreens, which often contain harmful xenobiotic ingredients that can absorb into the skin and contribute to ecological harm. Sóliome's approach allows customers to protect their skin from harmful rays without the adverse effects associated with conventional sunscreen formulations.

Sóliome is a biotechnology company founded in 2021 and based in San Francisco, California. The company specializes in developing protein-based sunscreens designed to be safe for both the skin and the environment. These innovative products aim to reduce inflammation and skin damage caused by traditional sunscreens, which often contain harmful xenobiotic ingredients that can absorb into the skin and contribute to ecological harm. Sóliome's approach allows customers to protect their skin from harmful rays without the adverse effects associated with conventional sunscreen formulations.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

Veloz Bio is a biotechnology company established in 2021 and located in Monterrey, Nuevo León. The company specializes in molecular farming to develop and manufacture sustainable and affordable animal-free and alternative proteins. By leveraging efficient plant metabolism, Veloz Bio has created a rapid protein production system that enables scalable growth of new proteins. This innovation allows biotech firms to gain expertise in essential areas of protein production, including supercritical fluid extraction and membrane purification. Through its focus on alternative proteins, Veloz Bio aims to contribute to a more sustainable food supply.

Veloz Bio is a biotechnology company established in 2021 and located in Monterrey, Nuevo León. The company specializes in molecular farming to develop and manufacture sustainable and affordable animal-free and alternative proteins. By leveraging efficient plant metabolism, Veloz Bio has created a rapid protein production system that enables scalable growth of new proteins. This innovation allows biotech firms to gain expertise in essential areas of protein production, including supercritical fluid extraction and membrane purification. Through its focus on alternative proteins, Veloz Bio aims to contribute to a more sustainable food supply.

ZymoChem, Inc. develops microbes and bioprocesses that enable production of chemicals from renewable sources, such as sugars. The company was founded in 2013 and is based in Emeryville, California.

Pyrone Systems develops biopesticides that combine biology with chemistry. The company was founded in 2021.

Pyrone Systems develops biopesticides that combine biology with chemistry. The company was founded in 2021.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

ZymoChem, Inc. develops microbes and bioprocesses that enable production of chemicals from renewable sources, such as sugars. The company was founded in 2013 and is based in Emeryville, California.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

Rizlab Health is a medical device startup founded in 2018 and based in East Princeton. The company specializes in providing practitioners and patients with rapid blood count readings, specifically focusing on white blood cell analysis. Rizlab Health's electronic cytometer and analyzer utilize a cartridge system to quantify key cellular components, such as neutrophils and lymphocytes. This technology enables hospitals and healthcare providers to quickly and affordably monitor patients' white blood counts, which is crucial for diagnosing conditions like sepsis and distinguishing between bacterial and viral infections. By offering a fast, portable, and cost-effective health monitoring solution, Rizlab Health aims to enhance patient care and streamline clinical decision-making processes.

Rizlab Health is a medical device startup founded in 2018 and based in East Princeton. The company specializes in providing practitioners and patients with rapid blood count readings, specifically focusing on white blood cell analysis. Rizlab Health's electronic cytometer and analyzer utilize a cartridge system to quantify key cellular components, such as neutrophils and lymphocytes. This technology enables hospitals and healthcare providers to quickly and affordably monitor patients' white blood counts, which is crucial for diagnosing conditions like sepsis and distinguishing between bacterial and viral infections. By offering a fast, portable, and cost-effective health monitoring solution, Rizlab Health aims to enhance patient care and streamline clinical decision-making processes.

Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Inflammatory disease affects us all. We looked 300 million years into our past to imagine a healthier future, beyond the limitations of today’s anti-inflammatory drugs. Lupa Bio is developing an entirely new class of safer, anti-inflammatory therapeutics based on compounds found in mothers’ milk ...because no technology today can screen like the forces of nature. ​

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Wayfinder Biosciences develops biosensors for ultra-high-throughput screening for high-value molecules. The company's PerfectPath biosensors make invisible molecules visible. These biosensors generate fluorescence based on the concentration of the desired small-molecule — allowing quantification of product titer at high-throughput using fast fluorescence measurements. Wayfinder Biosciences was established in 2021 and is headquartered in San Francisco, CA.

Wayfinder Biosciences develops biosensors for ultra-high-throughput screening for high-value molecules. The company's PerfectPath biosensors make invisible molecules visible. These biosensors generate fluorescence based on the concentration of the desired small-molecule — allowing quantification of product titer at high-throughput using fast fluorescence measurements. Wayfinder Biosciences was established in 2021 and is headquartered in San Francisco, CA.

Lux Bio operates a bioluminescent light platform that harnesses the natural light produced by living organisms through biochemical reactions. The company focuses on developing innovative, eco-friendly lighting solutions that utilize engineered proteins derived from plants and animals, enhancing their performance for commercial use. By leveraging clean technology, Lux Bio aims to offer sustainable lighting options while preventing toxic chemical waste from contaminating oceans. Their flagship product, the Nyoka Light Wand, exemplifies this mission by providing a non-toxic alternative to traditional glow sticks, showcasing the potential of bioluminescence in everyday applications.

Lux Bio operates a bioluminescent light platform that harnesses the natural light produced by living organisms through biochemical reactions. The company focuses on developing innovative, eco-friendly lighting solutions that utilize engineered proteins derived from plants and animals, enhancing their performance for commercial use. By leveraging clean technology, Lux Bio aims to offer sustainable lighting options while preventing toxic chemical waste from contaminating oceans. Their flagship product, the Nyoka Light Wand, exemplifies this mission by providing a non-toxic alternative to traditional glow sticks, showcasing the potential of bioluminescence in everyday applications.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Biomage focuses on single-cell analysis to advance life sciences by providing innovative computational methods to derive insights from biological data. The company has developed the Biomage Single Cell Platform, which allows researchers to efficiently analyze single-cell RNA sequencing data. This platform transforms complex datasets into actionable biological insights, facilitating research in both academia and industry. By streamlining the data analysis process, Biomage empowers scientists to enhance drug target discovery while making the application of advanced sequencing technologies more accessible and cost-effective.

Operator of a biotechnology company intended to help people live as long, and well, as possible by rapidly developing advanced longevity technologies. The company's technology biologically integrates with a host wearer for bi-directional information exchange rather than relying on hardware probes, enabling patients to get their personal stem cells.

Operator of a biotechnology company intended to help people live as long, and well, as possible by rapidly developing advanced longevity technologies. The company's technology biologically integrates with a host wearer for bi-directional information exchange rather than relying on hardware probes, enabling patients to get their personal stem cells.

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms to create innovative plant-inspired proteins, such as brazzein, for applications in the food and beverage industries. Additionally, Magellan Life Sciences offers the XSeed platform, which leverages synthetic biology to advance the development of novel proteins aimed at enhancing the food, health, and nutrition sectors.

Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.

Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.

Inflammatory disease affects us all. We looked 300 million years into our past to imagine a healthier future, beyond the limitations of today’s anti-inflammatory drugs. Lupa Bio is developing an entirely new class of safer, anti-inflammatory therapeutics based on compounds found in mothers’ milk ...because no technology today can screen like the forces of nature. ​

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Cybele Microbiome offers a proprietary platform creates natural products in 16X less time than conventional manufacturing. The company was founded by Nicole Scott in 2017 and it is based in San Diego, California.

Cybele Microbiome offers a proprietary platform creates natural products in 16X less time than conventional manufacturing. The company was founded by Nicole Scott in 2017 and it is based in San Diego, California.

Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Biomage focuses on single-cell analysis to advance life sciences by providing innovative computational methods to derive insights from biological data. The company has developed the Biomage Single Cell Platform, which allows researchers to efficiently analyze single-cell RNA sequencing data. This platform transforms complex datasets into actionable biological insights, facilitating research in both academia and industry. By streamlining the data analysis process, Biomage empowers scientists to enhance drug target discovery while making the application of advanced sequencing technologies more accessible and cost-effective.

Biomage focuses on single-cell analysis to advance life sciences by providing innovative computational methods to derive insights from biological data. The company has developed the Biomage Single Cell Platform, which allows researchers to efficiently analyze single-cell RNA sequencing data. This platform transforms complex datasets into actionable biological insights, facilitating research in both academia and industry. By streamlining the data analysis process, Biomage empowers scientists to enhance drug target discovery while making the application of advanced sequencing technologies more accessible and cost-effective.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

BioLumen is a nutritional technology company that develops a patented dietary fiber technology platform that reduces the negative effect of a diet heavy in processed foods. BioLumen's technology is composed of insoluble dietary fiber matrix covered with a blend of food ingredients created from the latest drug delivery system research. The company's product, a nutraceutical, focuses on high risk individuals with prediabetes to help manage blood sugar levels, protect their liver from excess sugar and feed their gut microbiome, delivering health benefits. BioLumen was founded on 2018 and is headquartered in San Francisco, California.

Sothic Bioscience Ltd. operates as a biotech company in Ireland. The company develops LimuleX, a bio-production platform to make bio-identical replacement for naturally sourced limulus amebocyte lysate, as well as to remove the threatened horseshoe crab species from the pharmaceutical quality control supply chain. Sothic Bioscience Ltd. was founded in 2015 and is based in Cork, Ireland.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.

Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

Inflammatory disease affects us all. We looked 300 million years into our past to imagine a healthier future, beyond the limitations of today’s anti-inflammatory drugs. Lupa Bio is developing an entirely new class of safer, anti-inflammatory therapeutics based on compounds found in mothers’ milk ...because no technology today can screen like the forces of nature. ​

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

Pando Nutrition, Inc. is an animal microbiome company based in San Francisco, California, established in 2017. The company specializes in developing genetically engineered probiotics to enhance livestock health and performance while eliminating the need for antibiotics. Its innovative platform, known as Panbiotics, focuses on identifying and controlling methane emissions, thereby improving feed efficiency and profitability in livestock production. Pando Nutrition also addresses poultry health challenges, specifically targeting the pathogen Coccidiosis. By utilizing advanced biotechnology, the company creates yeast-based systems for animal feed that not only boost animal immunity but can also be tailored to produce essential amino acids and deliver other vital nutrients. This approach enables sustainable and efficient production processes, providing clients with access to affordable raw materials while contributing to the reduction of antibiotic dependence in agriculture.

Dahlia Biosciences specializes in the fields of biotechnology and DNA analysis and diagnostics. The company provides a single-cell RNA analysis tools for research and diagnostic applications. Dahlia Biosciences was founded in 2011 and headquartered in California, United States.

ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.

Microendo’s mission is to protect and care for the environment. Environmental damage due to climate change poses great risk to crop security. By harnessing the natural microbiota of the plants we develop products that are in harmony with the environment. We take the microorganisms from your own plants, identify their needs and provide you with a tailored biofertilizer. This biofertilizer is personalized to each crop, fully organic and naturally helps to increase crop health & crop yield.

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

11 Biomics LLC develops biological therapeutics for the cannabis industry. It offers small and large scale treatment and protection against fungal and bacterial diseases in cannabis and hemp. The company is based in Albuquerque, New Mexico.

Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

Biospin is an introducing a revolutionary microbial detection system that provides gold standard detection of pathogens for F&B, water, consumer goods and pharmaceutical products in real time.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.

Dahlia Biosciences specializes in the fields of biotechnology and DNA analysis and diagnostics. The company provides a single-cell RNA analysis tools for research and diagnostic applications. Dahlia Biosciences was founded in 2011 and headquartered in California, United States.

Osiris Therapeutics, Inc. is a biotechnology company specializing in regenerative medicine, focusing on the development and marketing of cellular products aimed at treating various medical conditions, including those related to inflammation, cardiovascular health, orthopedics, and wound healing. The company operates through two main segments: Therapeutics and Biosurgery. Its Therapeutics segment emphasizes the development of biologic stem cell drug candidates sourced from readily available and non-controversial materials. Osiris markets its products under several brand names, including Grafix, GrafixPL, Stravix, Cartiform, and BIO4. Founded in 1992 and based in Columbia, Maryland, Osiris has established partnerships with organizations such as the Department of Veterans Affairs, Department of Defense, Howmedica Osteonics Corp., and Mesoblast Limited. As of April 2019, Osiris operates as a subsidiary of Smith & Nephew plc, enhancing its capacity to improve patient health while aiming to reduce overall healthcare costs.

Osiris Bio

Biomathematica SAS is a biotechnology research firm that specializes in microbiome-related genomic data analysis, providing quantitative and predictive guidance to biotechnology and pharmaceutical companies. Founded in 2017 and based in Ajaccio, France, the company employs advanced techniques such as artificial intelligence, mathematical modeling, and simulation to analyze the microbiome. Its services include microbial genomics for data analysis and visualization, strain characterization for metabolic reconstruction, and the development of microbiome therapeutics including probiotics and prebiotics. Additionally, Biomathematica offers personalized microbiome solutions through simulations, in-silico experiment design for complex microbial studies, and in-silico clinical trials that evaluate therapies on virtual patient models. Through its innovative genome-scale metabolic models, Biomathematica aims to enhance understanding of biological processes and improve therapeutic outcomes.

ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms to create innovative plant-inspired proteins, such as brazzein, for applications in the food and beverage industries. Additionally, Magellan Life Sciences offers the XSeed platform, which leverages synthetic biology to advance the development of novel proteins aimed at enhancing the food, health, and nutrition sectors.

Encelo Laboratories Limited develops cell isolation tools that allows researchers, in academia and industry, non-invasive, on-demand, and remote access to an individual’s cells. Its product includes the Cell isolation cup that allows for the selective isolation of live cells from urine and preserves them for shipment. It offers its products and services to pharmaceutical companies, academic researchers, biobanks, and clinicians. The company was founded in 2017 and is based in London, United Kingdom.

Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

Dahlia Biosciences specializes in the fields of biotechnology and DNA analysis and diagnostics. The company provides a single-cell RNA analysis tools for research and diagnostic applications. Dahlia Biosciences was founded in 2011 and headquartered in California, United States.

Scaled Biolabs Inc. specializes in biotech research and development, focusing on enhancing the discovery and translation of cell therapies. Founded in 2016 and based in San Francisco, the company utilizes a miniaturized lab platform that integrates microfluidics, automation, and machine learning. This innovative Cell Therapy Discovery Engine allows biotech and pharmaceutical companies to simultaneously test hundreds of parameters across thousands of experiments, facilitating insights into cell-driven biology. By streamlining the development of cell-based products and processes, Scaled Biolabs aims to simplify manufacturing and reduce time to market, ultimately improving clinical outcomes. The company is also engaged in internal development of cell therapy assets, including a program funded by CIRM that targets iPSC-derived dopaminergic neurons as a potential treatment for Parkinson’s disease.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.

Hyasynth Bio is a Montreal-based company that specializes in the production of natural cannabinoid compounds. It focuses on developing innovative solutions for researchers, healthcare professionals, and patients dealing with conditions such as multiple sclerosis, epilepsy, Alzheimer's disease, chronic pain, inflammation, and muscular dystrophy. By leveraging a combination of traditional and modern biological technologies along with computational analysis, Hyasynth Bio aims to create effective drugs for a wide range of diseases. The company utilizes a scalable platform based on engineered microbes to enhance its drug development process, effectively addressing the needs of the medical community.

ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.

OneSkin Inc. is a biotechnology company based in San Francisco that focuses on developing advanced solutions for skin health, particularly in the realm of anti-aging. Established in 2016, the company specializes in creating animal-free 3D human skin models that allow for in vitro testing of skin care products and ingredients. These models facilitate the evaluation of the efficacy and safety of new anti-aging compounds through various assessments, including skin firmness, hydration, and repair. Additionally, OneSkin designs topical skin supplements made from vegan ingredients aimed at reducing the biological age of the skin by enhancing cellular repair and strengthening the skin barrier. By leveraging genomic data and advanced modeling techniques, OneSkin strives to create personalized skincare products that effectively address the root causes of skin aging and promote overall skin health.

SwaLife Biotech Limited is a company based in Cork, Ireland, that specializes in the development of medicinal compounds derived from plants. Founded in 2017, the company focuses on discovering, extracting, and synthesizing novel anticancer plant alkaloids aimed at addressing DNA damage response, which is a critical factor in cancer development. SwaLife Biotech has successfully developed five unique bioactive alkaloids that target proteins and enzymes involved in DNA damage response, specifically for applications in skin and breast cancer treatment. The company's product offerings include an anti-cancer drug, a cosmetic for sun UV protection, and treatments for rare diseases. By leveraging these plant-derived compounds, SwaLife Biotech aims to enhance therapeutic options for patients and address the challenges of drug resistance in cancer therapies.

Kaitek Labs is a biotechnology company based in Providencia, Chile, that specializes in the research, development, and production of bio-based kits designed for environmental monitoring. Founded in 2013 by Emilia Díaz, the company focuses on creating microbial optical sensors that detect harmful algal blooms (HABs) and their associated neurotoxins in shellfish. The kits provide a straightforward method for on-site detection of PSP toxicity, indicated by a color change from pink to orange, signaling contamination. This early detection capability helps prevent the risks of shellfish poisoning and mitigates potential economic losses for clients reliant on shellfish harvesting.

ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.

Hyasynth Bio is a Montreal-based company that specializes in the production of natural cannabinoid compounds. It focuses on developing innovative solutions for researchers, healthcare professionals, and patients dealing with conditions such as multiple sclerosis, epilepsy, Alzheimer's disease, chronic pain, inflammation, and muscular dystrophy. By leveraging a combination of traditional and modern biological technologies along with computational analysis, Hyasynth Bio aims to create effective drugs for a wide range of diseases. The company utilizes a scalable platform based on engineered microbes to enhance its drug development process, effectively addressing the needs of the medical community.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.

Scaled Biolabs Inc. specializes in biotech research and development, focusing on enhancing the discovery and translation of cell therapies. Founded in 2016 and based in San Francisco, the company utilizes a miniaturized lab platform that integrates microfluidics, automation, and machine learning. This innovative Cell Therapy Discovery Engine allows biotech and pharmaceutical companies to simultaneously test hundreds of parameters across thousands of experiments, facilitating insights into cell-driven biology. By streamlining the development of cell-based products and processes, Scaled Biolabs aims to simplify manufacturing and reduce time to market, ultimately improving clinical outcomes. The company is also engaged in internal development of cell therapy assets, including a program funded by CIRM that targets iPSC-derived dopaminergic neurons as a potential treatment for Parkinson’s disease.

Pure Cultures LLC is a contract fermentation company based in Denver, Colorado, specializing in the production of probiotics for both human and animal health. Established in 2012, the company offers a variety of single and multiple strain probiotic blends, including lactobacillus acidophilus and plantarum, as well as custom silage inoculation blends tailored to meet the specific needs of clients. Pure Cultures employs diverse fermentation reactors, ranging from bench-top to large-scale production, utilizing advanced technology for media development, harvesting, and preservation of probiotic cultures. The company is committed to assisting clients through the entire process from concept to commercialization, ensuring quick turnaround times. Additionally, Pure Cultures provides expertise on regulatory compliance related to probiotic production and engages in strain-specific research and development, offering insights into innovative probiotic delivery methods and formula combinations.

BlueTurtleBio Technologies creates a next generation therapeutic using a patent pending platform technology. The company's mission is the golden triangle of healthcare: safety, effectiveness and affordability. Most healthcare options miss one or more of these standards. At Blue Turtle, they plan to recruit a genetically malleable and easily replenishable organ in the human body: the microbiome.

Scaled Biolabs Inc. specializes in biotech research and development, focusing on enhancing the discovery and translation of cell therapies. Founded in 2016 and based in San Francisco, the company utilizes a miniaturized lab platform that integrates microfluidics, automation, and machine learning. This innovative Cell Therapy Discovery Engine allows biotech and pharmaceutical companies to simultaneously test hundreds of parameters across thousands of experiments, facilitating insights into cell-driven biology. By streamlining the development of cell-based products and processes, Scaled Biolabs aims to simplify manufacturing and reduce time to market, ultimately improving clinical outcomes. The company is also engaged in internal development of cell therapy assets, including a program funded by CIRM that targets iPSC-derived dopaminergic neurons as a potential treatment for Parkinson’s disease.

Sothic Bioscience Ltd. operates as a biotech company in Ireland. The company develops LimuleX, a bio-production platform to make bio-identical replacement for naturally sourced limulus amebocyte lysate, as well as to remove the threatened horseshoe crab species from the pharmaceutical quality control supply chain. Sothic Bioscience Ltd. was founded in 2015 and is based in Cork, Ireland.

Cell Reserves Inc. manufactures protein and peptide-based therapeutics for the treatment of diseases. It manufactures bio-pharmaceuticals using molecular shields that increase the bio-availability of therapeutics in circulation. Cell Reserves Inc. is based in Ottawa, Canada.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.